Research Article
Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma
Figure 2
Comparison of PFS and OS between different groups of HCC patients. (a) PFS between CTC-positive and CTC-negative groups; (b) OS between CTC-positive and CTC-negative groups; (c) PFS between RFA and non-RFA groups in CTC-positive HCC patients; (d) PFS between RFA and non-RFA groups in CTC- negative HCC patients; (e) OS between RFA and non-RFA groups in CTC-positive HCC patients; (f) OS between RFA and non-RFA groups in CTC-negative HCC patients. (g) PFS between RFA and nontreatment groups in CTC-positive HCC patients; (h) OS between RFA and nontreatment groups in CTC-positive HCC patients.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |